Urokinase lysis for acute left subclavian artery thrombosis after placement of infusion catheter: report of two cases.
We present two cases of acute subclavian and/or axillary arterial occlusion after transaxillary catheterization with an implantable port for hepatic arterial infusion chemotherapy. They were successfully treated with thrombolytic therapy using intraarterial administration of urokinase without removal of the infusion catheter system. We consider that this treatment is suitable for managing acute thrombosis of the conduit artery after catheterization for hepatic arterial infusion chemotherapy.
Seki
Hiroshi
H
Department of Radiology, Niigata University School of Medicine, 757, 1-bancho, Asahimachi-dori, Niigata 951-8510, Japan. hseki@med.niigata-u.ac.jp
Kimura
Motomasa
M
Yoshimura
Norihiko
N
Takano
Tooru
T
Takaki
Satoshi
S
Awaji
Masanori
M
Sakai
Kunio
K
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000209:etiology*; D002406:Catheterization, Peripheral; D005500:Follow-Up Studies; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011859:Radiography; D018570:Risk Assessment; D013348:Subclavian Artery / Q000000981:diagnostic imaging / Q000187:drug effects; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014568:Urokinase-Type Plasminogen Activator